• QMC is in the process of completing an NI 43-101-compliant mineral resource estimate
• The company is anticipating a significant expansion of the historical mineral estimate
• The company has discovered and initiated exploration of additional dikes within the project area

The current evolution in computer and vehicle technology, fueled by the lightweight lithium-ion battery, is igniting interest in new lithium production. This has led mineral explorer QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) to push forward, as it continues developing a NI 43-101-compliant resource estimate as the next step toward potential commercial production of lithium at its Irgon Dike in southeast Manitoba. The company also continues to evaluate additional pegmatite dikes known to occur within the project area, with very positive results. The Irgon lithium mine project in Manitoba is part of the Cat Lake-Winnipeg River Pegmatite Field, which also hosts the world-renowned Tantalum Mining Corporation of Canada (TANCO) operation. TANCO is North America’s most successful spodumene and rare element pegmatite-hosted mine.

To update the historic data, QMC recently completed an 18-hole diamond drill program on the Irgon Dike for a total of 2,300 meters of drilling. The core was shipped to SGS Canada’s Lakefield laboratory for assay of 56 elements, including lithium, beryllium, rubidium, cesium, tantalum and niobium (http://ibn.fm/YXagt). The deepest hole in the 2019 drill campaign cut 14 meters (not true width) of spodumene-bearing pegmatite approximately 130 meters below the surface of the dike, which is well below the 61-meter level of the historic underground exploration, and this intersection confirms that significant spodumene mineralization continues to depth. Initial drill site evaluation of the core by QMC geologists visually identified significant white spodumene mineralization. The core has been cut and sampled, producing examples which were subsequently sent to SGS Lakefield for assay.

QMC believes that it will be able to double the historic mineral estimate of the property. In addition to exploring the spodumene-bearing Mapetre and Central Dikes, both located south of the Irgon Dike, the company has also identified the Irgon West spodumene-bearing pegmatite trending up to 400 meters (1,312.3 feet) west of, and on strike with, the Irgon Dike. As exploration on the property continues, potential tonnage from the Mapetre and Central Dikes, as well as the Irgon West Dike that has been identified as being the potential western extension of the Irgon Dike, suggests that the Irgon Project resource could be significantly increased.

QMC recently reported that assays of surface samples from its Mapetre, Central and Irgon West Dikes, located within the Irgon lithium mine project, identified significant occurrences of spodumene-bearing pegmatite mineralization. Analyses of 10 chip samples obtained from these three dikes identified zones that demonstrate very encouraging levels of lithium oxide, ranging from 2.34 percent over a sample length of 4.1 meters in the Central Dike to 2.79 percent across 7.0 meters in the Irgon West Dike. All samples were analyzed by SGS Laboratory in Lakefield, Ontario. SGS Canada is the consultant providing the NI 43-101-compatible resource report on the Irgon Dike.

“The Company is excited with these initial sampling results as they demonstrate a huge potential to develop additional tonnage within the Irgon Lithium Property (in addition to that tonnage currently being defined by SGS Canada that exists within the upper central portion of the Irgon Dike) as numerous pegmatite dikes on the property host significant spodumene mineralization,” President and CEO Balraj Mann stated in the April 24 announcement (http://ibn.fm/NLNpm). “An exploration program consisting of overburden stripping and channel sampling of the mineralized dikes is being planned for the upcoming field season to fully define the width, strike length and lithium grade of these dikes.”

For more information, visit the company’s website at www.QMCMinerals.com

NOTE TO INVESTORS: The latest news and updates relating to QMCQF are available in the company’s newsroom at http://ibn.fm/QMCQF

• The United States’ foreign trade policy may affect heavy oil supplies as the country enforces sanctions against Venezuela and Iran
• Petroteq Energy is revolutionizing the production of heavy oil by using a patented surface fuel extraction process to lessen environmental impacts and investigative financial risks
• Petroteq is conducting its operations at a leased bituminous fuel site in eastern Utah with a goal of proving the capabilities of its technology
• The company began delivering oil to its regional market in November and is working to increase the amount of quality crude it produces to new benchmarks

Fuel industry technology developer Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is pioneering a surface oil extraction process that promises to revolutionize an industry galvanized by the domestic sourcing prowess of fracking drills, particularly as international trade policy concerns affect petroleum imports.

Shale fracking, or hydraulic fracturing, has provided the United States with an abundant homegrown source of fuel oils via an extraction process that involves injecting highly pressurized water and chemicals into drilled wells to force open rock fractures and release trapped oil.

New uses of the fracking production process have created a boom in domestic oil production at a time when much of the nation is pushing to support homegrown industries over foreign imports. Recent governmental policy that has established trade sanctions on Venezuela’s and Iran’s oil exports (http://ibn.fm/8rkn0) is also helping to create a reduction in available medium-to-heavy grades of fuel.

The denser oils are in demand for refined products like jet fuel that are important to large, strong industries, and for low-sulfur fuel products favored by industries dealing with tighter shipping emissions rules.

Petroteq’s patented process produces heavy oils squeezed from surface pockets of bituminous shale in a closed-loop “clean” cycle that avoids many of the financial risks and uncertainties associated with exploring for crude sources deep underground. In particular, once a surface asphalt resource has been visually identified, there is no significant investment risk on the company’s part related to exploration, because the extent of the resource is already known prior to set up.

Petroteq’s process also has the advantage of being perhaps the most environmentally friendly of any extraction mechanism. It is a first-of-its-kind technology in which oil sands are mixed with a solvent solution, crushed to squeeze out the oil, shaken and then heat distilled to remove the oil for storage. The original sand material is returned to the desert floor cleaner than when it was taken for processing.

The solvent used in the process is recycled so that it can be used again and again in new cycles of oil extraction, helping the company to avoid some of the concerns associated with other processes that dump solvents back into the ground, or potentially compromise ground water that may serve as a source for area drinking water.

The company is now into commercial production, leasing a site in eastern Utah where it extracts the bituminous asphalt and produces heavy oil through its patented process. It is approaching an output of 1,000 barrels per day and will soon launch into Phase 2 of its production cycle, working toward a 4,000 bpd level in 2020. Petroteq envisions potentially producing 8,000 bpd by the end of 2020 as further proof of its technology’s efficacy (http://ibn.fm/Twolf).

For more information, visit the company’s website at www.Petroteq.energy

NOTE TO INVESTORS: The latest news and updates relating to PQEFF are available in the company’s newsroom at http://ibn.fm/PQEFF

• The company’s common shares will trade on the OTCQB Venture Market under ticker symbol ‘PNNRF’
• Uplisting is expected to raise Redfund Capital’s visibility with the U.S. investment community and increase overall global exposure
• Common stock liquidity is also likely to increase as a result of OTCQB trading

Global merchant bank Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (Frankfurt: O3X4) recently announced that it has uplisted to the OTCQB Venture Market as of April 30, 2019. According to a company press release, Redfund Capital’s common shares have been approved for OTCQB uplisting and will continue to trade under ticker symbol ‘PNNRF’ (http://ibn.fm/6rPQ5).

With a primary focus on financing medical cannabis, hemp and CBD companies, Vancouver-based Redfund Capital will continue trading on the Canadian Securities Exchange under ticker symbol ‘LOAN’, as well as on the Frankfurt Stock Exchange under symbol ‘O3X4’.

The uplisting is a significant milestone for Redfund Capital, which has undergone a rigorous process to become eligible for trading on the OTC Markets Group-operated venture market, according to CEO Meris Kott. To become eligible, a company needs to undergo annual verification and management certification, file up-to-date and complete financial reports and pass a minimum bid price test. In return, OTCQB trading stands as a guarantee for transparency, regulation and technology standards that improve the trading experience for investors.

Redfund Capital management welcomed the uplisting as an opportunity for increased exposure to investors. “Even though Redfund has been a fully reporting company since its inception and listing to the Canadian Securities Exchange, or CSE, we believe that the broader exposure afforded by the OTCQB will raise our visibility within the U.S. investment community and assist in increasing the liquidity of our common stock,” Kott explained in a news release.

In addition, trading on this established public market will help generate even more exposure for the company with institutional investors in Canada, the U.S. and Europe, the Redfund Capital CEO believes.

Redfund’s core business strategy is to provide equity and debt funding to companies in mid-to-late stages of development, with revenues of more than $2 million or a minimum of $1 million in the pipeline. The company considers itself the first cannabis merchant bank debt facility, as its present focus is to provide loans to companies in the medical cannabis, hemp and CBD and health care fields.

To further strengthen its business model, Redfund Capital recently announced a strategic partnership with the Cannabis Mercantile Exchange (“Cannamerx”) on the latter’s first international global hemp and CBD auction platform (http://ibn.fm/zVHPS). Under the partnership agreement, announced on March 20, Redfund will provide the fully automated B2B auction platform with funding to establish its business model and build a global clientele for cannabis products in Canada, the U.S. and Europe. The first transaction on the platform was expected to consist of 1.5 metric tons of hemp biomass, the companies announced.

In addition to providing funding for the auction platform, Redfund Capital offered financing to three cannabis companies during the first quarter of 2019 (RxMM Health, Mary’s Wellness Ltd. and Winterlife Inc.), established an investment in Wahupta Ventures Inc. (http://ibn.fm/QF0mk) and provided funding for the Cannaki Beverage Company (http://ibn.fm/BnCOX).

Redfund Capital’s goal is to have a portfolio of 20 companies with $75 million injected via loans to organizations looking to go global and become leaders in their markets, according to Kott. By establishing a strong, diverse portfolio, the company aims to generate significant monthly interest income that provides added value for shareholders.

For more information, visit the company’s website at www.RedfundCapital.com

NOTE TO INVESTORS: The latest news and updates relating to PNNRF are available in the company’s newsroom at http://ibn.fm/PNNRF

• Kontrol CEO stated in a news release that KNR exited 2018 with a $16 million annualized run rate and positive adjusted EBITDA in Q4
• In Q4, KNR reported a 100 percent YOY increase in sales from the comparable period in 2017
• The sales increase was attributed to a combination of organic growth and accretive acquisitions

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) recently announced sharply higher sales in FY2018, driven by a 100 percent YOY performance gain in Q4. For FY2018, which ended December 31, 2018, KNR reported $10.7 million in sales, marking a 56 percent YOY increase from $6.9 million in 2017. The company likewise recorded a 100 percent jump in revenues for Q4 to $4.1 million, up from $2.0 million in the prior year (http://ibn.fm/almss).

A combination of organic growth and accretive acquisitions was responsible for KNR’s 2018 performance, the company reported. In addition to the 100 percent YOY sales increase in Q4, the company recorded a $200,685 positive adjusted EBITDA, as compared with a negative $43,737 for the same period of the prior year.

An investor conference call discussing the results was conducted live on April 30. The call will be archived for one year on the company’s website.

“We exit 2018 with a revenue run rate of $16 million annualized,” Kontrol CEO Paul Ghezzi stated in a news release. “With our continued organic growth and next acquisition target announced, we look forward to a robust fiscal 2019.”

KNR is an Ontario, Canada-based innovator in the energy efficiency sector, offering clients market-based, green-energy solutions to reduce energy costs and cut GHG emissions. The company achieves this by applying disruptive and integrated technologies. The aim of KNR is to be an industry leader, providing energy efficiency and emission compliance solutions utilizing IoT, cloud and SaaS technology to reduce energy costs. It recently launched its SmartSuite energy management technology for the global commercial, multiresidential and hospitality real estate markets.

KNR’s strategy is a combination of organic growth and strategic accretive acquisitions. In 2018, KNR bought the operating assets of MCW Dimax Ltd., a specialist in the application of energy analysis software. KNR later acquired the IT formerly licensed to MCW Dimax, which includes two U.S. patents and one Canadian patent (http://ibn.fm/MYqkF). It also acquired CEM Specialties Inc., a market leader in emission monitoring, solutions and equipment.

For more information, visit the company’s website at www.KontrolEnergy.com

NOTE TO INVESTORS: The latest news and updates relating to KNRLF are available in the company’s newsroom at http://ibn.fm/KNRLF

• Siyata Mobile facilitates communications with unique cellular devices
• The company’s flagship product is the Uniden UV350
• Siyata sees considerable opportunity in the North American marketplace

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a worldwide developer and provider of cellular communications solutions for enterprise customers. In 2012, the company developed the world’s first 3G-connected vehicle device. In 2018, Siyata brought to market the world’s first 4G LTE all-in-one fleet communications device (http://ibn.fm/Bysgm). The company’s specialty is connected vehicle products for professional fleets, marketed under the Uniden Cellular brand. Siyata Mobile is headquartered in Montreal, Quebec, with its research and development operations in Israel.

Siyata’s goal is to provide the highest quality and the most technologically advanced mobile communication devices for international corporate workforces, fleets, homes and buildings. Fundamentally, Siyata is facilitating cellular communications with inventive cellular devices. Its customers include cellular operators, commercial vehicle technology distributors and fleets of all sizes in Canada, the United States, Europe, Australia and the Middle East. A top global developer and provider of Push-to-Talk (PTT/PoC) systems for enterprise customers, Siyata Mobile was named among the TSX Venture Top 50 for 2018 (http://ibn.fm/ADRwX).

Siyata Mobile’s PTT (4G/LTE) devices solve today’s modern communication problems and provide a safer, more efficient experience. Moreover, the devices are designed to replace clients’ traditional, antiquated systems for commercial, enterprise and government communication needs (http://ibn.fm/cW0Ti). Siyata’s devices eliminate engine and road noise, minimize vehicle echo and sound-quality problems, replace cluttered and costly tech solutions and are resistant to extreme temperatures. In addition, they work with all networks and extend cellular and GPS coverage.

Siyata’s flagship product is the Uniden UV350. The Uniden UV350 is purposely designed for commercial vehicles to ensure safer communications for professional drivers. This product is the only all-in-one in-vehicle device currently offered worldwide (http://ibn.fm/NOOcl). The Uniden UV350 is enabled with Push-to-Talk Over Cellular, data applications and more.

Siyata’s Uniden CP250 is a top 4G/LTE all-in-one tablet-style, fleet communications device designed for cellular voice calls, Push-to-Talk Over Cellular and navigation. The device features data applications, a built-in camera and DVR. It is also designed to be mounted on the vehicle dash or on a windshield, particularly for lighter commercial vehicles.

The company’s Uniden UR7 is the first 4G/LTE strong smartphone in a clamshell form factor. The IP67 device features 4G speed and crystal-clear cellular call quality through dual speakers. The UR7 also features dedicated PTT and SOS buttons and a touch screen (http://ibn.fm/1gWQK).

Siyata Mobile’s product line clearly offers robust handheld phones for industrial users. The company also offers signal boosters for homes and buildings, as well as fleets with poor cell coverage. Uniden Cellular Signal Boosters work with all 3G and 4G networks and cellular service providers. The boosters foster clear phone calls and extremely fast data speeds in facilities that are troubled with weak cellular signals (http://ibn.fm/7hMLZ).

With the Uniden UV350 completing network approval with two North American Tier 1 operators, Siyata Mobile is positioning to gain significant market share. Future recurring revenue from third-party fleet application sales is also a company focus. Of note for investors is that Siyata Mobile sees significant opportunity in the United States, where aging two-way LMR technology in approximately 9.7 million commercial trucks potentially needs to be replaced. Siyata’s Push-to-Talk Over Cellular looks to be an ideal candidate.

For more information, visit the company’s website at www.SiyataMobile.com

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF

• Lexaria continues to create a strong, revenue-generating business model to support its growing patent portfolio
• The company out-licenses disruptive delivery technology, giving licensees access to existing patents
• Lexaria entered into a new beverage license agreement with a California-based cannabis firm
• The company recently announced four new appointments to its scientific advisory board

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a drug-delivery platform innovator with existing cannabinoid licensing agreements in Canada and the United States, as well as internationally. By out-licensing disruptive delivery technology DehydraTECH, the company has created a strong, revenue-generating business model and a growing patent portfolio.

At the end of 2018, LXRP held 10 granted patents, with 53 patent applications filed and pending in more than 40 countries around the world. The company is unique in that it is the only global company with patents issued for the oral delivery of all cannabinoids. DehydraTECH has patents for cannabidiol (CBD), all other non-psychoactive cannabinoids, other psychoactive compounds, fat-soluble vitamins, NSAIDs (nonsteroidal anti-inflammatory drugs such as ibuprofen), nicotine and other molecules.

Lexaria out-licenses DehydraTECH, giving licensees access to its many existing patents. These patents include combinations of ready-to-drink beverages, wine, coffee, tea, sports drinks, supplements and more. Third-party partners and start-up businesses are currently paying royalties for cannabinoid licensing agreements, and a Fortune 100 company has licensed Lexaria’s technology for oral nicotine delivery in the U.S.

The company continues to grow additional revenue streams. On April 24, 2019, Lexaria announced (http://ibn.fm/6cRnl) its entry into a new beverage license agreement with a private California-based cannabis company. The financial terms of the definitive five-year agreement were not disclosed. LXRP’s patented DehydraTECH technology will be used by the private company in producing and selling cannabis-based beverages in California and Nevada. Last year, Lexaria announced that a Canadian company had licensed its technology to produce cannabis beverages in Canada.

DehydraTECH is unique in that it promotes healthier ingestion methods. The technology improves taste, rapidity and delivery of bioactive compounds while removing odor. This allows cannabinoids and other bioactive compounds to be delivered in high-quality food products and beverages without the need for additional sugars. It also provides a safer means of ingestion than the more traditional method of smoking.

In addition, Lexaria continues to strengthen its scientific research and product development team and has appointed four new members to its scientific advisory board. “Lexaria is building towards becoming one of the world’s leaders in drug-delivery technology, and our most recent advisors can assist in achieving that goal,” Lexaria CEO Chris Bunka stated in a news release.

To learn more about the background, interests and expertise that each new appointment brings to the company, read the announcement at http://ibn.fm/LwZ8R. These new board members will be providing critical scientific guidance to the company’s ongoing and future research and development programs.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Nightfood is revolutionizing the way people snack at night
• The company recently announced upcoming production runs in May and June, totaling over 330,000 pints, to prepare for new national distribution deal
• Nightfood Holdings CEO Sean Folkson described the company’s upcoming ventures in a SmallCapVoice.com interview

Nightfood Holdings Inc. (OTCQB: NGTF), an innovative consumer goods and brand development company, is pioneering the category of “sleep-friendly” nutrition with the national roll-out of its award-winning Nightfood ice cream. Leading marketing intelligence agency Mintel noted that nighttime-specific food and beverages represent one of the “most compelling and category changing” trends for the coming years (http://ibn.fm/fBtZr). Nightfood aims to revolutionize the way Americans snack at night.

Nightfood founder and CEO Sean Folkson was featured last week in an interview hosted by Stuart Smith of SmallCapVoice.com. In the interview, Folkson discussed Nightfood ice cream’s national rollout through major supermarket chains such as Meijer and Lowes Foods. Folkson also discussed a new distribution deal that he expects to have a massive impact on distribution and revenue in 2019 and beyond.

“We have a deal that we’re expecting to sign in the next couple of days that’s going to dramatically expand our footprint immediately, [bringing] us coast-to-coast right here in 2019,” Folkson said in a news release (http://ibn.fm/Xh8tR). “I’m projecting that it’s going to bring exponential growth to us in the next several quarters.”

Now that the company has publicly announced that this distribution deal has been signed, it is ramping up production to fulfill projected demand (http://ibn.fm/vGDwj). In the next 60 days, the company plans to produce over 330,000 pints of ice cream, enough for well over $1 million in revenue.

Jim Christensen is Nightfood’s VP of ice cream sales. Christensen spent more than 20 years at Unilever, where he held the same position and headed up sales and distribution initiatives for Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen noted in a release that the company anticipates monthly production runs with ever-increasing run volumes.

Folkson also recently discussed his company’s approach to social media marketing. He described “investomers” as individuals who both have an ownership stake in a company and also consume its products, and he believes that the “growing army of Nightfood investomers will accelerate the word-of-mouth [brand awareness] that so often catapults innovative new brands into public awareness and national distribution.”

Researchers estimate that most at-home ice cream consumption occurs in the hours before bed. The team at Nightfood, which includes America’s most prominent sleep expert, Dr. Michael Breus, has created an ice cream line specifically designed for nighttime snackers.

Recently, Nightfood ice cream was announced as the winner of the 2019 ‘Product of the Year’ award in the ice cream category in a survey of more than 40,000 consumers (http://ibn.fm/IAjjG).

For more information, visit the company’s website at www.Nightfood.com

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• SPRWF has remained at the center of the cannabis space since 2014
• The company has a licensed producer subsidiary in Ontario
• Supreme Cannabis recently launched new subsidiary Cambium Plant Sciences
• Bank of America recently initiated coverage with an initial ‘Buy’ rating

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) is Canada’s only large-scale premium cannabis producer. The company formed its wholly owned 7ACRES subsidiary as the first licensed producer (“LP”) centered on growing high-quality cannabis in high quantities. 7ACRES provides enthusiasts with handcrafted cannabis flower that delivers a premier experience. Headquartered in Toronto, Supreme Cannabis has supply agreements in place throughout eight of the 10 Canadian provinces.

Supreme Cannabis’ 7ACRES operates a 440,000-square-foot facility in Kincardine, Ontario, including licensed flower room space totaling 180,000 square feet. 7ACRES is on course to become Canada’s foremost cultivator of consistently first-rate commercial cannabis. With its recently-expanded flowering room, 7ACRES’ yearly production capacity estimate increased from roughly 17,500 kg to 26,250 kg. The company expects that, with additional production efficiencies following the licensing of all 25 of its flowering rooms, 7ACRES’ potential capacity could reach about 50,000 kg annually (http://ibn.fm/BqnC3).

In addition to 7ACRES, Supreme Cannabis’ brands include wholly owned subsidiary Cambium Plant Sciences, a cannabis genetics firm. The company recently announced the launch of Cambium Plant Sciences, which is located in Goderich, Ontario (http://ibn.fm/aHYAF). Additionally, its brands include a worldwide partnership with Khalifa Kush Enterprises (“KKE”), led by musician Wiz Khalifa, and its investment in Medigrow Lesotho.

Supreme Cannabis’ strategic agreement with KKE is for cannabis-related consulting services and the development and commercialization of distinct product lines (http://ibn.fm/Ki4qs). KKE will provide cannabis-related consulting services to Supreme Cannabis, while SPRWF will be the exclusive producer of KKE-branded products in Canada and, subject to certain approvals, globally, excluding the United States (http://ibn.fm/zFaf7).

In 2018, Supreme Cannabis entered into a definitive agreement to complete a $10 million strategic equity investment in Medigrow Lesotho (PTY) Limited. Medigrow Lesotho is a federally-licensed producer of cannabis in the Kingdom of Lesotho in southern Africa. Via this distribution partnership, CBD (cannabidiol) oil is expected to be exported to Canada and other global markets in the European Union and South America. Medigrow is licensed by the Lesotho Ministry of Health to cultivate and manufacture medical cannabis and cannabis oil products (http://ibn.fm/w2nIo).

In conjunction with Supreme Cannabis’ recent launch of Cambium Plant Sciences, the company is investing approximately $14 million in the construction of a state-of-the-art, 34,000-square-foot research and development facility in Goderich. Cambium’s aim is to lead the agricultural revolution of cannabis genetics, redefining consumer experiences and cultivation economics across the international cannabis industry.

“Cambium will develop cultivars that benefit our in-house brands, as well as our domestic and global cultivation and manufacturing partners,” Navdeep Dhaliwal, Supreme Cannabis’ CEO, stated in a news release. “Initially, Cambium is expected to benefit from 7ACRES’ established genetics, existing infrastructure and unparalleled plant knowledge of its team.” The expectation is that Supreme Cannabis will begin the retrofitting of the Cambium facility in early summer of this year. Moreover, Cambium Plant Sciences has begun the Health Canada licensing process.

In addition, on April 17, 2019, Bank of America Merrill Lynch (“BofA”) announced the initiation of coverage of the company with a ‘Buy’ rating and a C$2.50 price objective, according to an official coverage initiation announcement issued by the investment bank.

According to BofA, there are several factors that contribute to the attractiveness of Supreme Cannabis. Approximately 80 percent of the Supreme Cannabis production is sold in Canada. Supreme is selling in bulk at a similar price range to that of its peers in retail. This means that the Supreme Cannabis pricing model is the same, but the margin delivery format is higher. Moreover, Supreme Cannabis trades at the low-end of the BofA coverage group on E/V sales, which makes it attractive on DCF. BofA estimates that Supreme Cannabis sales will grow from C$9 million in 2018 to C$234 million in 2022. The growth on an annual basis will be 234 percent in 2020, slowing down to 64 percent in 2021 and 36 percent in 2022. Gross profits are also set for growth, from C$2 million in 2018 to C$131 million in 2022, at a rate of over 263 percent in 2020, 91 percent in 2021 and 44 percent in 2022, according to BofA estimates.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

• Branded cannabis products grew 637 percent more than non-branded products between 2014 and 2018
• Edibles continue to assure investors of stable market prices as compared to concentrates and flower products
• Plus Products anticipates enormous growth in production capacity as it constructs a large-scale manufacturing plant

Leading California edibles manufacturer Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) is making moves to dominate the branded cannabis industry through its continued focus on premium products executed with precision and made available to consumers everywhere.

The team at Plus Products realizes that the cannabis industry is moving toward branded products and sees brand strategy as key to accessing strong profit growth. In California alone, non-branded cannabis products grew by 64 percent between Q1 2014 and Q1 2018, while branded products saw retail growth of 701 percent in that same period. The company sees brand recognition as an integral component to its continued success in this market.

Looking forward, Plus Products is maintaining its focus on edibles, a segment that is on an upward trend. Between 2014 and 2018, the edibles market in Colorado alone rose from 12 percent to 16 percent of the cannabis space; in California, its market share rose from 13 percent to 16 percent between 2017 and 2018 (http://ibn.fm/Q6icJ). In addition, the edibles price point has shown steady growth since 2014, while various other products, such as concentrates and flower, have shown a steep decline, clearly distinguishing edibles as a product type that could be worthy of long-term investment.

Notably, Plus Products was ranked as the number one edibles brand in California as of Q3 2018, according to data from both BDS Analytics and Headset, achieving impressive retail success in the world’s most competitive cannabis market (http://ibn.fm/CpC9x). Currently, California offers the most competitive climate for cannabis companies, hosting almost 250 different edible brands while Colorado has less than 100. California is also the largest cannabis market worldwide, and it’s expected to grow to $5 billion in 2019 legal sales (http://ibn.fm/D6KoR).

BDS Analytics and Headset also report that Plus Products’ unit sales have grown 97 percent from Q2 2018 to Q3 2018. Moreover, Plus Products anticipates the construction of “the largest food grade manufacturing plant in the state with room to expand,” enabling the potential for $450 million in production capacity (http://ibn.fm/mfszZ). The company’s goal is to own the branded product space by pairing disciplined, agile food manufacturing with thoughtful branding teams.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• Trxade Group helps independent pharmacies identify the best supplier prices for prescription drugs
• The company’s trading platform allows independent pharmacies to stay informed about up-to-the-minute pricing on a cost-effective basis
• Trxade provides its services to pharmacies and consumers

An integrated pharmaceutical services company, Trxade Group Inc. (OTCQB: TRXD) offers an S2P (Supplier to Pharmacy) market platform. The platform helps independent pharmacies operating nationwide to identify the best available supplier prices for prescription drugs. Trxade is the largest online pharmaceutical marketplace platform in the United States. Per corporate data, the platform has been shown to reduce a pharmacy’s total yearly purchase costs by 7-10 percent (http://ibn.fm/vMKt1).

Headquartered out of Land O’ Lakes, Florida, Trxade Group brings pharmaceutical buyers and sellers together. The company’s strategy is to use price analytics and supplier competition to pass considerable advantages directly to its members. Its focus is on the best pricing and availability of generic and branded pharmaceuticals. Trxade’s platform maintains a wide-ranging generic and branded pharmaceutical portfolio that is accessible to community pharmacies across the nation.

The Trxade platform allows a third of the approximately 24,000 independent pharmacies in the United States to keep abreast of up-to-the-minute pricing on a cost-effective basis. Pharmacies pay no membership or transaction fees for using the platform, which offers access to numerous supplier sources. In addition, the platform has an easy layout for price comparison and purchasing. Trxade Exchange also opens and expands the distribution channel to retail and community pharmacies (http://ibn.fm/NwZid).

Trxade Group earns a transaction fee from sellers on the trading platform. The company charges 5 percent on each transaction value for generic drugs and 0.25 percent for branded drugs. Trxade Group also focuses on the consumer side of the pharmaceutical industry, offering drug price transparency and efficient buying. The company also facilitates delivery of drugs directly to independent pharmacists and consumers, operating a full-service mail order pharmacy for U.S. consumers. Furthermore, the Trxade Group Delivmeds mobile app enables same-day home delivery of dispensed prescriptions.

The company also offers RX Guru (http://ibn.fm/J7zmB). This price-prediction model integrates product shortage insight into pharmacy acquisition benchmarks to determine trends and pricing variances that could result in major purchasing opportunities. Fundamentally, RX Guru provides its members with an opportunity to benefit from real price-purchasing opportunities that are often concealed from the rest of the industry.

With its proprietary technology and extensive database, Trxade Group is poised to further penetrate its target market of independent pharmacies and their $93 billion of annual purchases. For investors, the company offers the potential for significant returns due to its low-risk, high-return business model. With a strategy focused on adding new industry sectors, such as hospitals, veterinarians and long-term care, Trxade Group continues to advance its initiatives for organic growth.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD